Changsha-based Sinocare Group makes blood glucose meters, continuous glucose monitors and other chronic disease diagnostic devices.
Established in 2002 in Changsha, China, Sinocare Group began as a biosensor manufacturer focused on diabetes and chronic disease management. It acquired two US companies in 2016, Nipro Diagnostics Inc. (renamed Trividia Health Inc.) and PTS Diagnostics Inc. The company runs seven R&D centers and eight production bases, serves over 25 million users in 135 countries and regions, and is listed on the Shenzhen Stock Exchange under code 300298.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in